Literature DB >> 12838408

The extracellular matrix protein betaIG-H3 is expressed at myotendinous junctions and supports muscle cell adhesion.

Jill W Ferguson1, Brian S Thoma, Michelle F Mikesh, Randall H Kramer, Kelly L Bennett, Anthony Purchio, Bradford J Bellard, Richard G LeBaron.   

Abstract

Molecules of the extracellular matrix (ECM) play important roles in the development and maintenance of myotendinous junctions (MTJs), specialized regions of muscle to bone union. In this report we provide evidence that skeletal muscle cells synthesize the collagen- and fibronectin-binding ECM protein betaIG-H3 and that betaIG-H3 is localized to MTJs. In situ hybridization experiments revealed that during E16.5-E18.5 of murine development, betaIG-H3 RNA transcripts were expressed where developing skeletal muscle fibers contact primordial cartilage and bone. Immunohistochemical analysis verified that the betaIG-H3 protein itself localized distinctively at MTJs, and ultrastructural analysis suggested that betaIG-H3 associates with extracellular fibers and the surface of cells. In vitro, recombinant betaIG-H3 functioned as an adhesion substratum for skeletal muscle cells. Adhesion was significantly reduced by anti-integrin alpha7 and beta1 antibodies, suggesting that betaIG-H3 binds to skeletal muscle cells via alpha7beta1 integrin. Localization of betaIG-H3 to the termini of skeletal muscle fibers and the binding of betaIG-H3 to cells and to molecules of the ECM suggests that betaIG-H3 may play an organizational and structural role in developing MTJs, linking skeletal muscle to components of the ECM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838408     DOI: 10.1007/s00441-003-0743-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  17 in total

1.  Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilization.

Authors:  Jarl Underhaug; Heidi Koldsø; Kasper Runager; Jakob Toudahl Nielsen; Charlotte S Sørensen; Torsten Kristensen; Daniel E Otzen; Henrik Karring; Anders Malmendal; Birgit Schiøtt; Jan J Enghild; Niels Chr Nielsen
Journal:  Biochim Biophys Acta       Date:  2013-10-12

2.  Myt3 Mediates Laminin-V/Integrin-β1-Induced Islet-Cell Migration via Tgfbi.

Authors:  Bryan R Tennant; Jenny Chen; Alexis Z L Shih; Dan S Luciani; Brad G Hoffman
Journal:  Mol Endocrinol       Date:  2015-07-15

3.  Unique TGFBI protein in lattice corneal dystrophy.

Authors:  Yu-Ping Han; Austin J Sim; Smita C Vora; Andrew J W Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

4.  Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.

Authors:  Sang Hun Shin; Jaeyoon Kim; Soon Chul Heo; Yang Woo Kwon; Young Mi Kim; In-San Kim; Taehoon G Lee; Jae Ho Kim
Journal:  Mol Cell Proteomics       Date:  2011-12-07       Impact factor: 5.911

5.  Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp.

Authors:  Kasper Runager; Rajiv V Basaiawmoit; Taru Deva; Maria Andreasen; Zuzana Valnickova; Charlotte S Sørensen; Henrik Karring; Ida B Thøgersen; Gunna Christiansen; Jarl Underhaug; Torsten Kristensen; Niels Chr Nielsen; Gordon K Klintworth; Daniel E Otzen; Jan J Enghild
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

6.  Inhibition of human scleral fibroblast cell attachment to collagen type I by TGFBIp.

Authors:  Lilian Shelton; Jody A Summers Rada
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-22       Impact factor: 4.799

7.  TGFBI (βIG-H3) is a diabetes-risk gene based on mouse and human genetic studies.

Authors:  Bing Han; Hongyu Luo; John Raelson; Jie Huang; Yun Li; Johanne Tremblay; Bing Hu; Shijie Qi; Jiangping Wu
Journal:  Hum Mol Genet       Date:  2014-04-11       Impact factor: 6.150

8.  C-terminal fragment of transforming growth factor beta-induced protein (TGFBIp) is required for apoptosis in human osteosarcoma cells.

Authors:  Rogelio Zamilpa; Rajesha Rupaimoole; Clyde F Phelix; Maria Somaraki-Cormier; William Haskins; Reto Asmis; Richard G LeBaron
Journal:  Matrix Biol       Date:  2009-06-06       Impact factor: 11.583

9.  Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.

Authors:  Chaoyu Ma; Yu Rong; Daniel R Radiloff; Michael B Datto; Barbara Centeno; Shideng Bao; Anthony Wai Ming Cheng; Fumin Lin; Shibo Jiang; Timothy J Yeatman; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2008-02-01       Impact factor: 11.361

10.  Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene.

Authors:  Henrik Karring; Zuzana Valnickova; Ida B Thøgersen; Chris J Hedegaard; Torben Møller-Pedersen; Torsten Kristensen; Gordon K Klintworth; Jan J Enghild
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.